BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 14707069)

  • 1. Early growth response gene 3 regulates thymocyte proliferation during the transition from CD4-CD8- to CD4+CD8+.
    Xi H; Kersh GJ
    J Immunol; 2004 Jan; 172(2):964-71. PubMed ID: 14707069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
    Barndt R; Dai MF; Zhuang Y
    J Immunol; 1999 Sep; 163(6):3331-43. PubMed ID: 10477603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature TCR alpha beta expression and signaling in early thymocytes impair thymocyte expansion and partially block their development.
    Lacorazza HD; Tucek-Szabo C; Vasović LV; Remus K; Nikolich-Zugich J
    J Immunol; 2001 Mar; 166(5):3184-93. PubMed ID: 11207271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.
    Kohu K; Sato T; Ohno S; Hayashi K; Uchino R; Abe N; Nakazato M; Yoshida N; Kikuchi T; Iwakura Y; Inoue Y; Watanabe T; Habu S; Satake M
    J Immunol; 2005 Mar; 174(5):2627-36. PubMed ID: 15728469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained early growth response gene 3 expression inhibits the survival of CD4/CD8 double-positive thymocytes.
    Xi H; Kersh GJ
    J Immunol; 2004 Jul; 173(1):340-8. PubMed ID: 15210792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
    Blank C; Brown I; Marks R; Nishimura H; Honjo T; Gajewski TF
    J Immunol; 2003 Nov; 171(9):4574-81. PubMed ID: 14568931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic expression of RasGRP1 induces the maturation of double-negative thymocytes and enhances the production of CD8 single-positive thymocytes.
    Norment AM; Bogatzki LY; Klinger M; Ojala EW; Bevan MJ; Kay RJ
    J Immunol; 2003 Feb; 170(3):1141-9. PubMed ID: 12538669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.
    Grueter B; Petter M; Egawa T; Laule-Kilian K; Aldrian CJ; Wuerch A; Ludwig Y; Fukuyama H; Wardemann H; Waldschuetz R; Möröy T; Taniuchi I; Steimle V; Littman DR; Ehlers M
    J Immunol; 2005 Aug; 175(3):1694-705. PubMed ID: 16034110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated p56lck directs maturation of both CD4 and CD8 single-positive thymocytes.
    Sohn SJ; Forbush KA; Pan XC; Perlmutter RM
    J Immunol; 2001 Feb; 166(4):2209-17. PubMed ID: 11160274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early onset of CD8 transgene expression inhibits the transition from DN3 to DP thymocytes.
    Wack A; Coles M; Norton T; Hostert A; Kioussis D
    J Immunol; 2000 Aug; 165(3):1236-42. PubMed ID: 10903721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factor independence-1B expression leads to defects in T cell activation, IL-7 receptor alpha expression, and T cell lineage commitment.
    Doan LL; Kitay MK; Yu Q; Singer A; Herblot S; Hoang T; Bear SE; Morse HC; Tsichlis PN; Grimes HL
    J Immunol; 2003 Mar; 170(5):2356-66. PubMed ID: 12594258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immature CD4+CD8+ thymocytes and mature T cells regulate Nur77 distinctly in response to TCR stimulation.
    Cunningham NR; Artim SC; Fornadel CM; Sellars MC; Edmonson SG; Scott G; Albino F; Mathur A; Punt JA
    J Immunol; 2006 Nov; 177(10):6660-6. PubMed ID: 17082578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ikaros null mice display defects in T cell selection and CD4 versus CD8 lineage decisions.
    Urban JA; Winandy S
    J Immunol; 2004 Oct; 173(7):4470-8. PubMed ID: 15383578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation.
    Ciofani M; Schmitt TM; Ciofani A; Michie AM; Cuburu N; Aublin A; Maryanski JL; Zúñiga-Pflücker JC
    J Immunol; 2004 May; 172(9):5230-9. PubMed ID: 15100261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CTLA-4 in the activation of single- and double-positive thymocytes.
    Kwon H; Jun HS; Khil LY; Yoon JW
    J Immunol; 2004 Dec; 173(11):6645-53. PubMed ID: 15557155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.
    Yasutomo K; Lucas B; Germain RN
    J Immunol; 2000 Sep; 165(6):3015-22. PubMed ID: 10975810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturation versus death of developing double-positive thymocytes reflects competing effects on Bcl-2 expression and can be regulated by the intensity of CD28 costimulation.
    McKean DJ; Huntoon CJ; Bell MP; Tai X; Sharrow S; Hedin KE; Conley A; Singer A
    J Immunol; 2001 Mar; 166(5):3468-75. PubMed ID: 11207305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status.
    Rodewald HR; Awad K; Moingeon P; D'Adamio L; Rabinowitz D; Shinkai Y; Alt FW; Reinherz EL
    J Exp Med; 1993 Apr; 177(4):1079-92. PubMed ID: 8096236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immature thymocyte antigen-1: a novel thymocyte marker discriminating pre- and post-selected thymocytes.
    Kishi H; Tong JJ; Nagata T; Muraguchi A
    Int Immunol; 1998 Jul; 10(7):951-60. PubMed ID: 9701033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Bim by TCR signals in CD4/CD8 double-positive thymocytes.
    Bunin A; Khwaja FW; Kersh GJ
    J Immunol; 2005 Aug; 175(3):1532-9. PubMed ID: 16034091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.